📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils. (2008)

First Author: Chan PH

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/bi8005797

PubMed Identifier: 18816062

Publication URI: http://europepmc.org/abstract/MED/18816062

Type: Journal Article/Review

Volume: 47

Parent Publication: Biochemistry

Issue: 42

ISSN: 0006-2960